Skip to content

Gross Profit at other companies

TFX
TeleflexTFX
$307.43M+20.4%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
Intuitive Surgical logo
Intuitive SurgicalISRG
$1.83B+25.6%
UFP Technologies logo
UFP TechnologiesUFPT
$44.36M+5.2%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$390.1M+16.1%
iRadimed logo
iRadimedIRMD
$16.81M+13.3%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-24.8%
Enterprise value$1.25B
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Calculated from PROCEPT BioRobotics Corporation’s reported figures.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's gross profit?
PROCEPT BioRobotics Corporation (PRCT) reported gross profit of $53.95M in Q1 2026.
How has PROCEPT BioRobotics Corporation's gross profit changed year-over-year?
PROCEPT BioRobotics Corporation's gross profit increased by 22.2% year-over-year, from $44.16M to $53.95M.
What is the long-term trend for PROCEPT BioRobotics Corporation's gross profit?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's gross profit has grown at a 87.5% compound annual growth rate (CAGR), from $15.87M to $196.23M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.